Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome.
about
Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based StudySignificance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Residual viremia is preceding viral blips and persistent low-level viremia in treated HIV-1 patients.Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mLHIV drug resistance detected during low-level viraemia is associated with subsequent virologic failureRate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens.HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective.Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter.A Single Quantifiable Viral Load Is Predictive of Virological Failure in Human Immunodeficiency Virus (HIV)-Infected Patients on Combination Antiretroviral Therapy: The Austrian HIV Cohort StudyIncomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation.Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.Reduced adherence to antiretroviral therapy is associated with residual low-level viremia.European Multicenter Study on Analytical Performance of Veris HIV-1 Assay.Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.Comparing Abbott m2000 RealTime HIV test and Roche COBAS Ampliprep/COBAS Taqman HIV test, v2.0 in treated HIV-1 B and non-B subjects with low viraemia.Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.Rate of and predicting factors for virologic failure in HIV-infected patients with persistent low-level viremia under antiretroviral therapy.Comparing HIV viral load assays and frequency of low level virological rebound in clinical practice.Low-level viremia is associated with non-B subtypes in patients infected with HIV with virological success following HAART introduction.
P2860
Q33653518-9A5794A3-C665-42B0-8CF8-F43571755F04Q33798584-2107F6F8-6DA0-4ACF-9507-B06476AAB177Q34420782-A388B3ED-6FB2-4C5E-A597-5C33E0B4D7B2Q34482990-6F233209-680C-4A7D-9699-72CB50DE5A76Q34781706-C2A85B5E-D3D6-44EB-9D64-43BB3F5D715AQ34869426-8B920F7F-05EA-430C-8545-8D1D290C0C7EQ35698144-63E5236F-0434-4A7D-A6E3-74A66D3806F5Q36826684-492E316D-D4DB-4BED-96EB-DBD15066EBEEQ37091685-99D06DF8-0C7F-47F9-98BD-07621D3EBF36Q38709087-6BD6F01D-C794-4D69-8C8F-2B20FCA3C2B5Q39422439-7E352828-EF74-4C24-AB93-AF5942F0B3ACQ40164081-A397892C-B836-49BB-926C-2BC5E6C92F77Q40235669-F53C58E7-2A9E-481D-BB22-D486792DC3B8Q40593936-D2294C96-3DC1-4062-9E99-B7BF6D651B27Q41020143-0A8BB08E-DDFF-4609-9DFD-79A5D337202FQ42211136-434202A4-582C-4445-B7E2-4F3631AF56BEQ42230066-9691522D-18F1-4871-9965-3CF5949FAB0DQ42230298-E752D0C0-907C-426D-A972-18A27FBEA2DDQ44913678-AD4EE716-13AF-4DF9-97B2-E0F35B899A2B
P2860
Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Persistent low-level HIV-1 RNA ...... ctors and virological outcome.
@en
Persistent low-level HIV-1 RNA ...... ctors and virological outcome.
@nl
type
label
Persistent low-level HIV-1 RNA ...... ctors and virological outcome.
@en
Persistent low-level HIV-1 RNA ...... ctors and virological outcome.
@nl
prefLabel
Persistent low-level HIV-1 RNA ...... ctors and virological outcome.
@en
Persistent low-level HIV-1 RNA ...... ctors and virological outcome.
@nl
P2093
P50
P356
P1476
Persistent low-level HIV-1 RNA ...... ctors and virological outcome.
@en
P2093
Cédric Laouénan
France Mentré
Gwenn Hamet
Patrick Yeni
Roland Landman
Véronique Joly
P304
P356
10.1093/JAC/DKS191
P407
P577
2012-05-29T00:00:00Z